RonaldSteisMD

Oncology • Cumming, GA

Physician

Join to view full profile

Dr. Steis is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Steis' full profile

Already have an account?

Office
1505 Northside Blvd
Ste 4600
Cumming, GA 30041
Phone+1 707-205-5292

Fax+1 770-740-9359

Education & Training

National Institutes of Health Clinical CenterFellowship, Hematology and Medical Oncology, 1981 - 1985
UPMC Medical EducationResidency, Internal Medicine, 1978 - 1981
University of Pittsburgh School of MedicineClass of 1978

Certifications & Licensure

GA State Medical License 1991 - 2023
MD State Medical License 1985 - 1991
PA State Medical License 1980 - 1982
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Medical Oncology

Awards, Honors, & Recognition

Top MD Consumers Checkbook

Clinical Trials

A Study of Rituximab Versus Iodine I 131 Tositumomab Therapy for Patients With Non-Hodgkin's Lymphoma Start of enrollment: 2004 Apr 01
Unknown status
Phase 3
Xcellerated T CellsTM for Non-Hodgkin's Lymphoma (NHL) Patients Start of enrollment: 2004 Mar 01
Unknown status
Phase 2
Relating Clinical Outcomes in Multiple Myeloma to Personal Assessment of Genetic Profile Start of enrollment: 2011 Jul 01
Completed
A Study of Rindopepimut/GM-CSF in Patients With Relapsed EGFRvIII-Positive Glioblastoma Start of enrollment: 2011 Dec 01
Completed
Phase 2
A Phase II/III Trial of Nivolumab, Ipilimumab, and GM-CSF in Patients With Advanced Melanoma Start of enrollment: 2015 Nov 23
RECRUITING
PHASE2, PHASE3
A Study of Relatlimab Plus Nivolumab Versus Nivolumab Alone in Participants With Advanced Melanoma Start of enrollment: 2018 Apr 11
Active, not recruiting
Phase 2, Phase 3
Join now to see all

Publications & Presentations

PubMed

30 citations
A randomized, double-blind, phase 2 study of ruxolitinib or placebo in combination with capecitabine in patients with advanced HER2-negative breast cancer and elevated...
Joyce O'Shaughnessy, Angela DeMichele, Cynthia X. Ma, Paul Richards, Denise A. Yardley
Breast Cancer Research and Treatment. 2018-04-19
2 citations
Safety of BTZ retreatment for patients with low-grade peripheral neuropathy during the initial treatment.
Aleksandra Vidisheva, James Wang, Tanya M. Spektor, Jacob D. Bitran, Jose Lutzky
Supportive Care in Cancer. 2017-04-28
49 citations
Cetuximab in combination with carboplatin and docetaxel for patients with metastatic or advanced-stage nonsmall cell lung cancer: a multicenter phase 2 study.
Chandra P. Belani, Marshall T. Schreeder, Ronald G. Steis, Richard A. Guidice, Thomas A. Marsland
Cancer. 2008-11-01